These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12774163)

  • 21. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
    Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Ozols E; Young MJ; Bennett BL; Friedman GC; Tesch GH
    Am J Nephrol; 2011; 34(4):337-46. PubMed ID: 21876346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
    Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension.
    Kohzuki M; Wu XM; Kamimoto M; Yoshida K; Nagasaka M; Kanazawa M; Yasujima M; Saito T; Sato T
    Am J Hypertens; 2000 Mar; 13(3):298-306. PubMed ID: 10777035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy.
    Gomes CL; Leão CL; Venturotti C; Barreira AL; Guimarães G; Fonseca RJ; Fortunato RS; Mourão PA; Delgado AG; Takiya CM; Leite M
    PLoS One; 2014; 9(9):e106929. PubMed ID: 25192337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.
    Biederman JI; Vera E; Rankhaniya R; Hassett C; Giannico G; Yee J; Cortes P
    Kidney Int; 2005 Feb; 67(2):554-65. PubMed ID: 15673303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cerivastatin on endothelial dysfunction and aortic CD36 expression in diabetic hyperlipidemic rats.
    Nakamura T; Saito Y; Ohyama Y; Uchiyama T; Sumino H; Kurabayashi M
    Hypertens Res; 2004 Aug; 27(8):589-98. PubMed ID: 15492479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
    J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.
    Pandey A; Goru SK; Kadakol A; Malek V; Sharma N; Gaikwad AB
    Biochimie; 2016 Dec; 131():68-76. PubMed ID: 27693081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin and taurine reduce early glomerulopathy in diabetic rats.
    Ha H; Yu MR; Kim KH
    Free Radic Biol Med; 1999 Apr; 26(7-8):944-50. PubMed ID: 10232838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes.
    Gross ML; Ritz E; Schoof A; Adamczak M; Koch A; Tulp O; Parkman A; El-Shakmak A; Szabo A; Amann K
    Lab Invest; 2004 Apr; 84(4):452-64. PubMed ID: 14767489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats.
    Wu Y; Wang Y; Qi X; Zhang P; Zhang C; Zhang W
    Nephron Exp Nephrol; 2014; 128(1-2):46-56. PubMed ID: 25376933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.